Clinical trials
Retinal Vein Occlusion trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 5 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Allergan | 3 |
| Bayer | 3 |
| University of Toronto | 3 |
| Regeneron Pharmaceuticals | 2 |
| Unity Health Toronto | 2 |
| Clearside Biomedical, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| University of Malta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 21 |
| Macular Edema | 11 |
| Macular Degeneration | 4 |
| Vision Disorders | 4 |
| Intracranial Thrombosis | 1 |
| Neovascularization, Pathologic | 1 |
| Retinal Artery Occlusion | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.